Nephroprotection of plantamajoside (cas 104777-68-6) in rats treated with cadmium
-
Add time:09/05/2019 Source:sciencedirect.com
Cadmium (Cd), an environmental and industrial pollutant, generates free radicals responsible for oxidative stress. Cd can also lead to various renal toxic damage such as the proximal tubules and glomerulus dysfunction. plantamajoside (cas 104777-68-6) (PMS), a major compound of Plantago asiatica (PA), was reported to have the antioxidant effects. In this study, we investigated the protective effects of PMS on Cd-induced renal damage in the NRK-52E cell and rat kidney tissue. Cd exposure increased the ROS generation, lipid peroxidation, serum biochemical values of renal damage, and mRNA and protein expressions of KIM-1 in vitro and in vivo. The significant reduction in glutathione (GSH)/glutathione disulfide (GSSG) ratio and activities of antioxidant enzymes were also observed in the rats treated with Cd. PMS significantly decreased the ROS generation and lipid peroxidation, thus enhancing GSH/GSSG ratio, antioxidant enzyme activities in the cells and rats, and improved histochemical appearances, indicating that PMS has protective activities against Cd-induced renal injury.
We also recommend Trading Suppliers and Manufacturers of plantamajoside (cas 104777-68-6). Pls Click Website Link as below: cas 104777-68-6 suppliers
Prev:Pharmacokinetics of plantamajoside (cas 104777-68-6) and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry
Next:plantamajoside (cas 104777-68-6) inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Structure and antibacterial activity of plantamajoside (cas 104777-68-6), a caffeic acid sugar ester from Plantago major subs major09/07/2019
- plantamajoside (cas 104777-68-6) inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells09/06/2019
- Pharmacokinetics of plantamajoside (cas 104777-68-6) and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry09/04/2019
- plantamajoside (cas 104777-68-6) ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation09/03/2019
- Invited mini reviewplantamajoside (cas 104777-68-6) — A current review09/02/2019
- plantamajoside (cas 104777-68-6) attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway09/01/2019
- plantamajoside (cas 104777-68-6) attenuates inflammatory response in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT signaling pathway08/31/2019